Universal Corporation is a global business-to-business agriproducts company headquartered in Richmond, Virginia. With more than 100 years of operating history, the company sources, processes, and supplies leaf tobacco to consumer tobacco manufacturers and provides plant-based ingredients to food and beverage markets. Its operations span more than 30 countries across five continents and are divided into two reporting segments: Tobacco Operations, the leading global leaf tobacco merchant business, and Ingredients Operations, which includes fruit and vegetable-based ingredients, botanical extracts, and other specialty products.
Investors follow UVV for its established role in the global tobacco supply chain, its long dividend history, and its diversification into ingredients. The company does not manufacture consumer tobacco products; it competes on global sourcing, traceability, processing capabilities, and customer relationships.
In the 30 days through August 12, 2026, UVV declined from a closing price of $50.98 on July 13 to a latest available price of $45.40, a drop of about 10.9%. The decline was concentrated in the first half of August, with elevated trading volume and a move below the stock's prior 52-week low.
Over the last quarter, the move is even larger. From a May 12 close of $53.71 to the latest available price of $45.40, UVV has fallen about 15.5%. The stock dropped sharply in late May after fiscal fourth-quarter results, recovered part of that decline in July, and then sold off again following the fiscal first-quarter update in August.
The biggest catalyst was the release of fiscal Q1 2027 results on August 5, 2026. Universal swung to a net loss of $5.0 million, or $0.20 per share, from net income of $8.5 million, or $0.34 per share, a year earlier. Adjusted EPS was a loss of $0.18, missing consensus expectations for a $0.25 profit. Revenue fell 11.8% year over year to $523.8 million, below estimates of roughly $587 million.
Pressure was concentrated in Tobacco Operations. Segment revenue fell 13% to $437.1 million, and operating income fell about 90% to $3.5 million. Management cited oversupply in flue-cured and burley tobacco markets, slower purchasing as customers evaluated green tobacco price trends, and more typical seasonal patterns. Tobacco volumes declined roughly 9% and prices fell about 6%. The Ingredients segment posted revenue of $86.7 million, down 3%, and an operating loss of $0.7 million.
Analyst and sentiment signals added to the selling pressure. Zacks upgraded UVV from "strong sell" to "hold" in early August, but Sidoti lowered fiscal 2027 EPS estimates, and the consensus rating remained Hold. A director's sale of 1,782 shares, disclosed after the earnings-driven decline, added a modest negative signal. The company maintained its $0.83 quarterly dividend, but the payout ratio remains elevated relative to trailing earnings.
The broader three-month decline was set in motion by Universal's fiscal Q4 2026 report, released May 28, 2026. The company recorded a quarterly net loss of $43.3 million, or $1.73 per diluted share, compared with net income of $9.3 million, or $0.37 per share, a year earlier. Results included a $41.1 million non-cash goodwill impairment tied to the Shank's business within Universal Ingredients and higher tobacco inventory write-downs.
For fiscal 2026, net income fell to $33 million from $95 million in fiscal 2025. Tobacco inventory write-downs rose to $43 million from $19 million, and Ingredients operating income declined to $3 million from $12 million. These results reset market expectations, sent the stock sharply lower in late May, and left UVV trading below its 50-day and 200-day moving averages as the latest quarter's results reinforced concerns about margin pressure and execution.
For traders seeking a more systematic way to monitor price moves like UVV's, Tickeron's Trending AI Robots page offers a curated view of AI-driven trading bots. Tickeron offers hundreds of AI trading bots trading thousands of tickers, but only top-performing and most relevant bots appear in this section. Bots vary by strategy, timeframe, and performance metrics, allowing traders to compare different systematic approaches across changing market conditions. Exploring the page can provide a data-driven complement to traditional stock research.
Investors will be watching whether management's expectation for second-half-weighted tobacco shipments begins to show up in financial results. Key factors include green tobacco price trends, the resolution of flue-cured and burley oversupply, and the pace at which uncommitted inventory normalizes toward the company's 10% to 20% target range. Crop conditions and potential El Niño effects also matter for sourcing costs.
In Ingredients, the leadership transition following the announced retirement of the segment's leader adds execution risk, while utilization at Shank's and consumer packaged goods demand remain areas of focus. Macroeconomic factors, including tariffs, input costs, and foreign exchange, could also influence margins. Finally, dividend sustainability and analyst estimate revisions will be closely monitored given the elevated payout ratio and weak trailing profitability. This information is not financial advice, and all investing involves risk.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UVV advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .
UVV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on July 31, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UVV as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for UVV turned negative on August 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .
UVV moved below its 50-day moving average on August 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for UVV crossed bearishly below the 50-day moving average on August 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UVV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for UVV entered a downward trend on July 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.805) is normal, around the industry mean (19.416). UVV has a moderately high P/E Ratio (59.066) as compared to the industry average of (24.151). UVV's Projected Growth (PEG Ratio) (12.366) is slightly higher than the industry average of (3.792). UVV has a moderately high Dividend Yield (0.073) as compared to the industry average of (0.047). UVV's P/S Ratio (0.396) is slightly lower than the industry average of (2.881).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. UVV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UVV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 67, placing this stock worse than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company that processes and distributes burley leaf tobaccos
Industry Tobacco